HALEOSLABS

Haleos Labs Share Price

 

 

Haleos Labs live price: ₹1287.3. It opened at ₹1,270 vs previous close ₹1,268; intraday high/low: ₹1,299/₹1,263. The 50 & 200 DMA stand at ₹1,267.60/₹1,242.11.

Haleos Labs Performance

  • Today's Low
  • ₹1,263
  • Today's High
  • ₹1,299
  • 52 Week Low
  • ₹1,067
  • 52 Week High
  • ₹1,680
  • Open Price₹1,270
  • Previous Close₹1,268
  • Volume474
  • 50 DMA₹1,267.60
  • 100 DMA₹1,261.80
  • 200 DMA₹1,242.11

Investment Returns

  • Over 1 Month + 1.12%
  • Over 3 Month -0.48%
  • Over 6 Month + 15.05%
  • Over 1 Year + 17.52%

Smart Investing Starts Here Start SIP with Haleos Labs for Steady Growth!

Invest Now

Haleos Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 19.6
  • PEG Ratio
  • -1.4
  • Market Cap Cr
  • 389
  • P/B Ratio
  • 1.8
  • Average True Range
  • 52.44
  • EPS
  • 65.65
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -0.68
  • RSI
  • 53.35
  • MFI
  • 65.08

Haleos Labs Financials

Haleos Labs Technicals

EMA & SMA

Current Price
₹1,287.30
+ 19.1 (1.51%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹1,268.41
  • 50 Day
  • ₹1,267.60
  • 100 Day
  • ₹1,261.80
  • 200 Day
  • ₹1,242.11

Resistance and Support

1283.2 Pivot Speed
  • R3 1,339.70
  • R2 1,319.50
  • R1 1,303.40
  • S1 1,267.10
  • S2 1,246.90
  • S3 1,230.80

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Haleos Labs Ltd has an operating revenue of Rs. 347.77 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 8% is okay, ROE of 10% is good. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 0% and 3% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 59 which is a POOR score indicating inconsistency in earnings, a RS Rating of 77 which is FAIR indicating the recent price performance, Buyer Demand at D- which indicates heavy supply, Group Rank of 48 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Haleos Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-11 Quarterly Results
2025-11-10 Quarterly Results
2025-08-11 Quarterly Results & A.G.M.
2025-05-29 Audited Results & Dividend
2025-02-12 Quarterly Results & Others To consider other business matters. per share(15%)Dividend
Date Purpose Remarks
2025-09-24 FINAL Rs.1.50 per share(15%)Dividend
View Haleos Labs Dividend History Arrow

Haleos Labs F&O

Haleos Labs Shareholding Pattern

71.8%
0%
24.6%
3.6%

Haleos Labs FAQs

Haleos Labs share price is ₹1,287 As on 11 April, 2026 | 13:58

The Market Cap of Haleos Labs is ₹389.2 Cr As on 11 April, 2026 | 13:58

The P/E ratio of Haleos Labs is 19.6 As on 11 April, 2026 | 13:58

The PB ratio of Haleos Labs is 1.8 As on 11 April, 2026 | 13:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23